Studies on metabolism of tazobactam/piperacillin in some animals

7Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The metabolism of tazobactam/piperacillin (TAZ/PIPC) in some animals was studied using in vitro and in vitro examinations. The following results were obtained. 1. After intravenous administration of 14C-TAZ/PIPC or TAZ/14C-PIPC to rats, metabolites were investigated in plasma, urine and bile. M-1 was identified as a metabolite of TAZ having a structure of the β-lactam ring-opening product. In the urine, about 70% of unchanged TAZ, about 17% of M-1, and about 25% of unchanged PIPC were excreted for 24h, and in the bile about 60% of unchanged PIPC was excreted for 24h. 2. Plasma and urinary bioactive metabolites in rats, dogs and monkeys were examined by TLC-bioautography. No bioactive metabolites were detected in any specimens. 3. In vitro, stability of TAZ in mice plasma and tissue homogenate was examined. The metabolite M-1 was produced in plasma, kidney and small intestine homogenates. © 1994, Japanese Society of Chemotherapy. All rights reserved.

Cite

CITATION STYLE

APA

Matsushita, H., Komuro, M., Maeda, T., Minami, Y., & Sakawa, K. (1994). Studies on metabolism of tazobactam/piperacillin in some animals. CHEMOTHERAPY, 42, 198–205. https://doi.org/10.11250/chemotherapy1953.42.Supplement2_198

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free